Search results for "Pregnancy complications"

showing 10 items of 490 documents

Extreme Methylation Values of Imprinted Genes in Human Abortions and Stillbirths

2010

Imprinted genes play an important role in fetal and placental development. Using quantitative bisulfite pyrosequencing assays, we determined the DNA methylation levels at two paternally methylated (H19 and MEG3) and four maternally methylated (LIT1, NESP55, PEG3, and SNRPN) imprinted regions in fetal muscle samples from abortions and stillbirths. Two of 55 (4%) spontaneous abortions and 10 of 57 (18%) stillbirths displayed hypermethylation in multiple genes. Interestingly, none of 34 induced abortions had extreme methylation values in multiple genes. All but two abortions/stillbirths with multiple methylation abnormalities were male, indicating that the male embryo may be more susceptible t…

GeneticsRegulation of gene expressionMEG3FetusMusclesShort CommunicationsGene Expression Regulation DevelopmentalAbortion InducedMethylationDNA MethylationStillbirthBiologyfemale genital diseases and pregnancy complicationsPathology and Forensic MedicineGenomic ImprintingFetusPregnancyembryonic structuresDNA methylationHumansFemaleAlleleGenomic imprintingGenereproductive and urinary physiologyThe American Journal of Pathology
researchProduct

Molecular and Cellular Insights into the Development of Uterine Fibroids

2021

Uterine leiomyomas represent the most common benign gynecologic tumor. These hormone-dependent smooth-muscle formations occur with an estimated prevalence of ~70% among women of reproductive age and cause symptoms including pain, abnormal uterine bleeding, infertility, and recurrent abortion. Despite the prevalence and public health impact of uterine leiomyomas, available treatments remain limited. Among the potential causes of leiomyomas, early hormonal exposure during periods of development may result in developmental reprogramming via epigenetic changes that persist in adulthood, leading to disease onset or progression. Recent developments in unbiased high-throughput sequencing technolog…

Genome instabilityInfertilitysteroid hormonesUterine fibroidsQH301-705.5ReviewBioinformaticsCatalysistumor-initiating cellEpigenesis GeneticInorganic Chemistrytumor bulk/single-cellsmedicineAnimalsHumansGenetic Predisposition to DiseaseEpigeneticsPhysical and Theoretical ChemistryBiology (General)Molecular BiologyQD1-999genetics/epigeneticsSpectroscopyUterine leiomyomauterine leiomyomaLeiomyomabusiness.industryOrganic ChemistryUterusMyometriumbiomarkersGeneral Medicinemedicine.diseasefemale genital diseases and pregnancy complicationsComputer Science ApplicationsGene Expression Regulation NeoplasticChemistryLeiomyomaMutationUterine Neoplasmstargetable pathwaysFemalebusinessReprogrammingInternational Journal of Molecular Sciences
researchProduct

Association of Gestational Weight Gain With Adverse Maternal and Infant Outcomes

2019

Importance: Both low and high gestational weight gain have been associated with adverse maternal and infant outcomes, but optimal gestational weight gain remains uncertain and not well defined for all prepregnancy weight ranges. Objectives: To examine the association of ranges of gestational weight gain with risk of adverse maternal and infant outcomes and estimate optimal gestational weight gain ranges across prepregnancy body mass index categories. Design, setting, and participants: Individual participant-level meta-analysis using data from 196 670 participants within 25 cohort studies from Europe and North America (main study sample). Optimal gestational weight gain ranges were estimated…

Gestational hypertensionNutrition and Disease01 natural sciencesBody Mass Index0302 clinical medicinePregnancyVoeding en ZiekteMedicineBirth Weight030212 general & internal medicineObstetricsDiabetesPregnancy OutcomeGestational ageGeneral MedicineCesarean Section/statistics & numerical dataAdult; Birth Weight; Cesarean Section; Diabetes Gestational; Female; Humans; Hypertension Pregnancy-Induced; Infant Newborn; Obesity; Pregnancy; Premature Birth; Body Mass Index; Gestational Weight Gain; Pregnancy Complications; Pregnancy OutcomeGestational Weight GainGestational diabetesPremature birthGestationalHypertensionPremature BirthFemalemedicine.symptomUnderweightPREGNANT-WOMENAdultmedicine.medical_specialtyBirth weightPregnancy-InducedHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciencesAll institutes and research themes of the Radboud University Medical CenterLife ScienceHumansObesity0101 mathematicsbusiness.industryCesarean Section010102 general mathematicsInfant NewbornInfantHypertension Pregnancy-Inducedmedicine.diseaseNewbornReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]BODY-MASS INDEXPregnancy ComplicationsDiabetes GestationalbusinessBody mass indexWeight gain
researchProduct

Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, …

2019

ObjectiveTo assess the separate and combined associations of maternal pre‐pregnancy body mass index (BMI) and gestational weight gain with the risks of pregnancy complications and their population impact.DesignIndividual participant data meta‐analysis of 39 cohorts.SettingEurope, North America, and Oceania.Population265 270 births.MethodsInformation on maternal pre‐pregnancy BMI, gestational weight gain, and pregnancy complications was obtained. Multilevel binary logistic regression models were used.Main outcome measuresGestational hypertension, pre‐eclampsia, gestational diabetes, preterm birth, small and large for gestational age at birth.ResultsHigher maternal pre‐pregnancy BMI and gesta…

Gestational hypertensionand promotion of well-beingNutrition and DiseaseBirthweightReproductive health and childbirthLow Birth Weight and Health of the NewbornCardiovascularMedical and Health SciencesDISEASECohort Studies0302 clinical medicine3123 Gynaecology and paediatricsRisk FactorsPregnancyVoeding en ZiekteInfant MortalityOdds RatioMedicineBirth Weight2.1 Biological and endogenous factorsEPIDEMIOLOGYwq_200Aetiology2. Zero hungerPediatricRISKeducation.field_of_studyOUTCOMES030219 obstetrics & reproductive medicineObstetricspregnancy complicationsDiabetesObstetrics and GynecologyGestational ageweight gainASSOCIATIONGestational Weight GainGestational diabetesEuropeBirthweight ; Body Mass Index ; Pregnancy Complications ; Preterm Birth ; Weight GainOBESITYFemalemedicine.symptomAdultmedicine.medical_specialtyPRETERM BIRTHBirth weightPopulationGestational Agebody mass index[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetricswa_310Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciencesAll institutes and research themes of the Radboud University Medical CenterPretermClinical ResearchHumanswq_100ObesityeducationObstetrics & Reproductive MedicineMetabolic and endocrineNutritionPregnancybusiness.industryContraception/ReproductionPreventionBirthweight; body mass index; pregnancy complications; preterm birth; weight gainAustraliaInfantbirth weightpreterm birthDIABETES-MELLITUSPreterm birth weight gainOverweightPerinatal Period - Conditions Originating in Perinatal Periodmedicine.diseaseNewbornPrevention of disease and conditionsReconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]Good Health and Well BeingNorth America3.1 Primary prevention interventions to modify behaviours or promote wellbeingpregnancy complicationbusinessWeight gainBody mass indexwb_200
researchProduct

Predictive Factors of Response to Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs): A Multi-Institutional Study

2019

Imatinib 400 mg is the standard of care for medical treatment of advanced GISTs. In the majority of cases, however, GISTs eventually develop resistance to imatinib. The optimal second line treatment has not been established yet and imatinib dose escalation (800 mg) or sunitinib represent two feasible options. The objective of this retrospective, multi-institutional, study is to analyze the validity of several parameters as possible predictive factors of response to sunitinib after imatinib failure. We reviewed 128 metastatic GISTs treated with sunitinib between January 2007 to June 2017. Primary tumour site, metastatic site, c-KIT/PDGFR-α mutational status, PET-FDG status and type…

GiSTSunitinibbusiness.industryImatinibmedicine.diseaseurologic and male genital diseasesImatinib resistantdigestive system diseasesfemale genital diseases and pregnancy complicationsmedicineCancer researchGastrointestinal stromal tumors (GISTs)businessneoplasmsmedicine.drugoncology_oncogenics
researchProduct

Obstetric and Neonatal Outcome of Pregnancies Fathered by Males on Immunosuppression After Solid Organ Transplantation

2015

Immunosuppressive drugs may influence spermatogenesis, but little is known about outcome of pregnancies fathered by transplanted males. We estimated risk of adverse outcomes in pregnancies (with data after the first trimester) fathered by males that had undergone organ transplantation and were treated with immunosuppression. A population-based study, linking data from the Norwegian transplant registry and the Medical Birth Registry of Norway during 1967-2009 was designed. All Norwegian men undergoing solid organ transplantation were included. Odds ratios for major malformations, preeclampsia, preterm delivery (<37 weeks) and small-for-gestational-age were obtained using logistic regression.…

Graft RejectionMaleimmunosuppressantmedicine.medical_treatmentOrgan transplantationCohort StudiesFathersPre-EclampsiaObstetrics and gynaecologyPregnancyRisk FactorsImmunology and AllergyPharmacology (medical)Registrieseducation.field_of_studyNorwayObstetricsPregnancy OutcomeImmunosuppressionMiddle Agedpracticesurgical procedures operativePremature BirthFemalepregnancyImmunosuppressive AgentsLung TransplantationAdultmedicine.medical_specialtyAdolescentPopulationCongenital AbnormalitiesPreeclampsiaYoung AdultmedicineHumansSpermatogenesiseducationRetrospective Studiesobstetrics and gynecologyTransplantationPregnancybusiness.industryOrgan TransplantationOdds ratiomedicine.diseasehealth services and outcomes researchKidney TransplantationLiver TransplantationSurgeryPregnancy ComplicationsTransplantationclinical researchHeart Transplantationbusiness
researchProduct

Successful treatment of HSV encephalitis during pregnancy.

1989

A propos d'une femme presentant une grossesse de 23 semaines. Description des signes cliniques et electroencephalographiques. Les effets de l'aciclovir sur l'encephalite et sur l'evolution de la grossesse sont etudies

GynecologyAdultPregnancymedicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentAcyclovirHerpes Simplexmedicine.diseasePregnancyImmunologymedicineGestationEncephalitisHumansFemaleNeurology (clinical)AciclovirHsv encephalitisPregnancy Complications InfectiousbusinessEncephalitismedicine.drugNeurology
researchProduct

UROEPITHELIAL DEFENSE IN CHILDREN WITH URINARY TRACT INFECTIONS (UTI)

1985

It is well accepted that obstructive uropathy causes UTI.In patients without urological anomalies a host defense defect of the uroepithelial cells (UEC) may result in increased susceptibility to bacterial infections.Even in patients with vesicourethral reflux (VUR) and recurrent UTI the postulated defense mechanism may be impaired since a significant proportion of these patients still suffer from UTI after surgical therapy.Therefore the influence of UEC on bacterial growth was investigated in 5 groups of children: healthy donors,children with neurogenic bladder due to myelomeningocele (MMC),patients with asymptomatic bacteriuria (ABU;without obstructive uropathy) and patients with VUR after…

Gynecologymedicine.medical_specialtybusiness.industryUrinary systemUrologyRefluxUrineurologic and male genital diseasesmedicine.diseasefemale genital diseases and pregnancy complicationsRpmi mediumRECURRENT UTIPediatrics Perinatology and Child HealthmedicineIn patientbusinessObstructive uropathyNeurogenic bladder dysfunctionPediatric Research
researchProduct

Lipid profile during pregnancy in HIV-infected women

2006

Purpose: We investigated the evolution of serum lipid levels in HIV-infected pregnant women and the potential effect of antiretroviral treatment during pregnancy using data from a national surveillance study. Method: Fasting lipid measurements collected during routine care in pregnancy were used, analyzing longitudinal changes and differences in lipid values at each trimester by protease inhibitors (Pls) and stavudine use. Multivariate analyses were used to control for simultaneous factors potentially leading to hyperlipidemia. Study population included 248 women. Results: Lipid values increased progressively and significantly during pregnancy: mean increases between the first and third tri…

HIV InfectionsTriglyceridechemistry.chemical_compoundPregnancyHiv infectedHyperlipidemiaHIV InfectionPharmacology (medical)Pregnancy Complications Infectioustriglyceridesmedicine.diagnostic_testStavudineStavudineHyperlipidemiaInfectious DiseasesTreatment OutcomeItalyPopulation SurveillancePopulation studylipids (amino acids peptides and proteins)FemalePregnancy TrimesterPregnancy TrimesterspregnancyHumanmedicine.drugAdultmedicine.medical_specialtyLogistic Modelprotease inhibitorsHyperlipidemiascholesterol; HIV; pregnancy; protease inhibitors; triglyceridesprotease inhibitorInternal medicinemedicineHumansHIV Protease InhibitorTriglyceridesPregnancyTriglycerideCholesterolbusiness.industryCholesterol HDLcholesterolHIVCholesterol LDLHIV Protease Inhibitorsmedicine.diseaseLipid MetabolismEndocrinologyLogistic ModelschemistryPregnancy Complications InfectiouHIV-1Lipid profilebusiness
researchProduct

Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with H…

2011

Abstract Background There is increasing evidence for the role of High Risk (HR) Human PapillomaVirus (HPV) in the pathogenesis of Oral Squamous Cell Carcinoma (OSCC). The E6 and E7 oncogenes from HR HPVs are responsible for the deregulation of p53 and pRB proteins involved in cell cycle and apoptotic pathways. In cell lines experiments, the HPV E7 protein seems to be able to enhance Hypoxia Inducible Factor-1 alpha (HIF-1α) activity, normally involved in the response to hypoxia and able to enhance angiogenesis. Results We studied tumor specimens from 62 OSCC; a higher prevalence of tumors in TNM stage II and also in pT2 class between OSCC infected positive HPV16 DNA than non-infected ones w…

HPV16Cancer ResearchPathologymedicine.medical_specialtyHPVNecrosisAngiogenesisEpidemiologyAlpha (ethology)BiologyOral Squamous Cell Carcinomalcsh:RC254-282lcsh:Infectious and parasitic diseasesPathogenesisHypoxia-Inducible Factor 1-Alphachemistry.chemical_compoundmedicinelcsh:RC109-216E7Oral Squamous Cell Carcinoma Hif-1α HPV HPV16 E7virus diseasesHypoxia (medical)lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensfemale genital diseases and pregnancy complicationsstomatognathic diseasesInfectious DiseaseschemistryOncologyApoptosisCancer researchmedicine.symptomHif-1αDNAResearch ArticleInfectious agents and cancer
researchProduct